Health stocks hit after Trump taps RFK for top job
The news prompted a sell-off across the industry. In the US, shares in Pfizer and Moderna sank more than 5% in early trading, while UK-listed firms AstraZeneca and GSK dropped 2% or more. Russ Mould, investment director at AJ Bell, said the pick had “spooked” shareholders, despite questions about how the new administration might pursue its threats.
I get Kennedy's appeal, but Trump will undo the protections with the most direct, proven impact on our health.
Daily Express US on MSN21m
RFK Jr's biggest controversies - from tap water and brain worms to Covid vaccineRobert F Kennedy Jr, nephew of John F Kennedy and son of Robert F Kennedy, has been named as Donald Trump's new Health ...
20mon MSN
On a windy afternoon in October 2015, a Black middle-aged man spoke from the famous Capitol steps on the United States ...
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
WASHINGTON — In the hours after President-elect Donald Trump announced that vaccine skeptic Robert F. Kennedy Jr. was his ...
Robert F. Kennedy Jr. would create “significantly more volatility” in health markets if he is confirmed as Secretary of ...
1h
Shares of COVID vaccine manufacturers Moderna and Pfizer fell early Friday morning, down 4% and 4.3% respectively.
Robert F. Kennedy Jr.'s journey from left-aligned skepticism into Trumpism is part of a broader trend of contemporary left-to ...
Mediaite on MSN1h
CNN’s Kaitlan Collins Rips RFK Jr. ‘Lies’ After Trump Announces Pick — With Blizzard Of ClipsKaitlan Collins tore apart Trump's selection of Robert F. Kennedy Jr. to lead the Department of Health and Human Services ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback